Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isoleucine is an essential branched-chain aliphatic amino acid required for human health and protein biosynthesis[1][7]. It cannot be synthesized by the human body and must be obtained from dietary sources or supplementation[3][7]. Isoleucine plays a critical role in hemoglobin synthesis and regulation of blood sugar and energy levels[1][4]. It also supports muscle growth and repair by participating in muscle protein synthesis as one of the three branched-chain amino acids (BCAAs), along with leucine and valine[3]. Additionally, it functions as a signaling molecule involved in glucose uptake by muscle cells and metabolic regulation[3][5]. Isoleucine is commonly used as a component of total parenteral nutrition (TPN) solutions to treat or prevent malnutrition or specific metabolic disorders such as maple syrup urine disease (MSUD), phenylketonuria (PKU), liver disease-related amino acid imbalances or muscle wasting conditions[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Isoleucine.